Camila Cubeddu

Camila joined LifeSci Consulting as an Analyst in 2026. She has a B.S. in Biology & Society and a minor in Business from Cornell University. Prior to joining LifeSci Camila was a Corporate Strategy Intern at Lupin Pharmaceuticals where she evaluated the impact of tariff policy on pharmaceutical operations and conducted competitive analysis of mergers and acquisitions to build speciality portfolio growth opportunities. In analyzing industry trends, product launches, and global business performances she grew interested in continuing to work on the business end of pharmaceuticals. She also served as a Research Intern at Georgetown University’s Lombardi Cancer Center, where she used bioinformatics tools to investigate gene regulators and biomarkers related to PFAS exposure and cancer development. Camila is passionate about the intersection of life science research, pharmaceuticals, and business. At LifeSci, she is excited to continue supporting the development and commercialization of innovative therapies through helping biopharmaceutical companies bring new medicines to market and improve patient access to care.